Dr. Lucky Tran13h ago

Pfizer just announced that its Lyme disease vaccine reduced the number of tick-borne infections by over 70% in a phase 3 trial.

Warning: GSK pulled a Lyme vaccine in 2002 despite studies showing it posed no serious safety risks.

Any new Lyme vaccine is going to be a huge target for antivaxxers.

Show threadChris Laprun ⏚
@luckytran pardon my ignorance but why would a Lyme disease vaccine be more of a target for antivaxxers than any other vaccines? Or is it just because it’s a *new* vaccine targeting something that wasn’t already covered?
6:52amIvory for iOS